EPS Creative Health Technology Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
33.00
-24.00
-48.00
-22.00
7.00
27.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-25.00
-7.00
0.00
18.00
-17.00
1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-20.00
-31.00
-40.00
3.00
-12.00
24.00
Cash Flow from Investing Activities
51.00
-21.00
-2.00
-1.00
0.00
0.00
Cash Flow from Financing Activities
-13.00
38.00
-25.00
111.00
-1.00
-9.00
Net Cash Inflow / Outflow
15.00
-15.00
-67.00
114.00
-14.00
14.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
0.00
0.00
2.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of EPS Creative Health Technology Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
33.416
94.6550307499293
-61.00
-64.70%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-25.292
-90.1694420886205
65.00
71.95%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-20.498
-3.0832999429644
-17.00
-564.81%
Cash Flow from Investing Activities
51.667
47.7201128351662
4.00
8.27%
Cash Flow from Financing Activities
-13.671
-38.5591439226722
25.00
64.55%
Net Cash Inflow / Outflow
15.151
5.54625251787551
10.00
173.18%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.347
-0.531416451654087
-2.00
-341.65%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 35.78% vs 20.76% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-20.50
-31.92
35.78%






